As early as 1995, SHK was reported as an inhibitor of DNA topoisomerase-I (Ahn et al., 1995), and SHK could inhibit growth and induce apoptosis of GSC and glioma cells by inhibiting topoisomerase-I (Zhang et al., 2013). This evidence concerns the gene SHPK and central nervous system cancer.